Zusammenfassung
In diesem Kapitel sollen die Prinzipien der hämatopoetischen Stammzelltransplantation als lebenserhaltende Maßnahme für zahlreiche hämatologische und onkologische Erkrankungen dargestellt werden. In den krankheitsspezifischen Kapiteln wird dann für die jeweiligen Erkrankungen eine kritische Bewertung der Transplantation im Kontext alternativer Therapieoptionen bzw. des Gesamtbehandlungskonzepts vorgenommen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adès L, Guardiola P, Socié G (2002) Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Reviews 16:135–146
Aird W, Labopin M, Gorin NC, Antin JH (1992) Long-term cryopreservation of human stem cells. Bone Marrow Transplant 9:487–490
Al Kasim FA, Thornley I, Rolland M et al. (2002) Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matchedrelated and matched-unrelated donor transplants. Br J Haematol 116:483–490
Anderlini P, Donato M, Chan KW et al (1999) Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39:555–560
Anderson D, Defor T, Burns L et al (2003) A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biol Blood Marrow Transplant 9:52–59
Antin JH, Childs R, Filipovich AH et al (2001) Establishment of complete and mixed chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings. Biol Blood Marrow Transplant 7:473–485
Antoine C, Müller S, Cant A et al (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560
Arora M, Burns LJ, Davies SM et al (2003) Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant 9:38–45
Ascioglu S, Rex JH, De-Pauw B et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14
Atkinson K (1990) Chronic graft-versus-host disease. Bone Marrow Transplant 5:69–82
Aversa F, Tabilio A, Terenzi A et al (1994) Successful engraftment of T-cell-depleted haploidentical »three-loci« incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948–3955
Aversa F, Tabilio A, Velardi A et al (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA-haplotype. N Engl J Med 339:1186–1193
Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM (1968) Bonemarrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2:1364–1366
Bacigalupo A, Brand R, Oneto R et al (2000) Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience. Semin Hematol 37:69
Bacigalupo A, Lamparelli T, Gualandi F et al (2002) Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants. Biol Blood Marrow Transplant 8:656–661
Bader P, Hancock J, Kreyenberg H et al (2002) Minimal residual di sease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 16:1668–1672
Bader P, Stoll K, Huber S et al (2000) Characterization of lineage-specific chimerism in patients with acute leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Hematol 108:761–768
Baron F, Beguin Y (2002) Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biol Blood marrow Transplant 8:351–359
Barrett AJ, Horowitz MM, Pollock BH et al (1994) Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 331:1253–1258
Baumann M, Korenke GC, Weddige-Diedrichs A et al (2003) Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur J Pediatr 162:6–14
Bensinger WI, Spielberger R (2004) Preparative regimens. In: Blume KG, Forman SJ, Appelbaum FR (eds) Thomas’ hematopoietic cell transplantation, pp 158–177. Blackwell Science, Boston
Bensinger WI, Martin PJ, Storer B et al (2001) Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175–181
Bensinger WI, Weaver CH, Appelbaum FR et al (1995) Transplan tation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655–1658
Borgmann A, Baumgarten E, Schmid H et al (1997) Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? Bone Marrow Transplant 20:939–944
Borgmann A, Schmid H, Hartmann R et al (1995) Autologous bonemarrow transplants compared with chemotherapy for children with acute lympoblastic leukaemia in a second remission: a matched-pair analysis. Lancet 346:873–876
Borgmann A, von Stackelberg A, Hartmann R, Ebell W et al (2003) Un related donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 101:3835–3839
Bortin MM, Buckner CD (1983) Major complications of marrow harvesting for transplantation. Exp Hematol 11:916–921
Boulad F, Steinherz P, Reyes B et al (1999) Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood lymphoblastic leukemia in second remission: a singleinstitution study. J Clin Oncol 17:197–207
Broxmeyer HE, Douglas GW, Hangoc G et al (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828–3832
Bunin N, Carston M, Wall D et al (2002) Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 99:3151–3157
Burt RK, Slavin S, Burns WH, Marmont A (2002) Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 99:768–784
Chakrabarti S, Mautner V, Osman H et al (2002) Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:1619–1627
Champlin RE, Schmitz N, Horowitz M et al (2000) Blood stem cells versus bone marrow as a source of haematopoietic cells for allogeneic transplantation. Blood 95:3702–3709
Couch RB, Englund JA, Whimbey E (1997) Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Infect Dis 102:2–9
Creutzig U, Reinhardt D, Zimmermann M et al (2001) Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies. Blood 97:3671–3672
Curtis RE, Rowlings PA, Deeg HJ et al (1997) Solid cancers after bone marrow transplantation. N Engl J Med 336:897–904
Deeg HJ, Henslee-Downee PJ (1990) Management of acute graftversus-host disease. Bone Marrow Transplant 6:1–8
Devergie A, Blaise D, Attal M et al (1995) Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood 85:2263–2268
Dopfer R, Henze G, Bender-Götze C, Ebell W et al (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM-und Co ALL-protocols: results of the German Cooperative Study. Blood 78:2780–2784
Down JD, Tarbell NJ, Thames HD, Mauch PM (1991) Syngenic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 77:661–669
Dutreix J, Janoray P, Bridier A et al (1986) Biologic and anatomic problems of lung shielding in whole-body irradiation. Natl Cancer Inst 76:1333–1335
Einsele H, Ehninger G, Hebart H et al (2001) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815–2820
Ekstrand K, Greven K, Wu Q (1997) The influence of x-ray energy on lung dose uniformity in total body irradiation. Int J Radiat Oncol Biol Phys 38:1131–1136
Feig SA, Harris RE, Sather HN (1997) Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children’s Cancer Group (CCG-1884). Med Pediatr Oncol 29:534–540
Friedrich W, Goldmann SF, Ebell W et al (1985) Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr 144:125–130
Führer M, Burdach S, Ebell W et al (1998) Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. Klin Pädiatr 210:173–179
Furlong T, Leisenring W, Storb R et al (2002) Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol Blood Marrow Transplant 8:206–212
Gatti RA, Meuwissen HJ, Allen HD et al (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366–1369
Gaziev J, Lucarelli G (2003) Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 15:24–31
Gianni AM, Siena S, Bregni M et al (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 9:580–583
Gluckman E (2001) Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med 344:1860–1861
Gluckman E, Auerbach AD, Horowitz M (1995) Bone marrow transplants in Fanconi anemia from the International Bone Marrow Transplant Registry. Blood 86:2856–2862
Gluckman E, Broxmeyer HE, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 321:174–178
Goldman JM, Melo JV (2003) Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med 349:1451–1464
Good RA, Verjee T (2001) Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Blood Marrow Transplant 7:123–135
Gratwohl A, Baldomero H, Passweg J et al (2003) Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 17:941–959
Grochow LB (2002) Parenteral busulfan: is therapeutic monitoring still warranted. Biol Blood Marrow Transplant 8:465–467
Grochow LB, Krivit W, Whitley CB, Blazar B (1990) Busulfan disposition in children. Blood 75:1723–1727
Haas R, Ho AD, Bredthauer U et al (1990) Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 18:94
Hancock JP, Goulden NJ, Oakhill A, Steward CG (2003) Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia 17:247–251
Handgretinger R, Klingebiel T, Lang T et al (2001) Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 8:777–783
Hansen JA, Clift RA, Thomas ED et al (1980) Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303:565–567
Hansen JA, Gooley TA, Martin PJ et al (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962–968
Harrison G, Richards S, Lawson S et al (2000) Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party. Ann Oncol 11:999–1006
Hildebrandt M, Serke S, Meyer O et al (2000) Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield. Transfusion 40:507–512
Holler E, Wodzynski A, Kolb HJ et al (2002) Adenovirus-and other respiratory virus infections in patients undergoing autologous or allogeneic stem cell transplantation. Final analysis of a prospective multicentre surveillance study. Onkologie 25:130
Hughes WT, Armstrong D, Bodey GP et al (1997) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25:551–573
Hurley CK, Baxter Lowe LA, Logan B et al (2003) National marrow donor program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant 9:610–615
Kardos G, Baumann I, Passmore SJ et al (2003) Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 102:1997–2003
Kashyap A, Wingard J, Cagnoni P et al (2002) Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biol Blood Marrow Transplant 8:493–500
Kemshead JT, Treleaven J, Heath L et al (1987) Monoclonal antibodies and magnetic microspheres for the depletion of leukemic cells from bone marrow harvested for autologous transplantation. Bone Marrow Transplant 2:133–139
Kern WV, Beyer J, Böhme A et al (2000) Infektionsprophylaxe bei neutropenischen Patienten — Leitlinien der Arbeitsgemeinschaft Infektionen in der Hämatologie und Onkologie. Dtsch Med Wochenschr 125:1582–1586
Kernan NA (1998) T-cell depletion for the prevention of graft-versushost disease. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, pp 186–196. Blackwell Science, Boston
Klein AK, Patel DD, Gooding ME et al (2001) T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 7:454–466
Klingebiel T, Bader P, Bares R et al (1998) Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study. Eur J Cancer 34:1398–1402
Kolb HJ, Schmid C, Chen X et al (2003) Adoptive immunotherapy in chimeras with donor lymphocytes. Acta Haematol 110:110–120
Körbling M, Fliedner TM, Calvo W et al (1979) Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): longterm allogeneic engraftment without GVH-reaction. Exp Hematol 7:277–288
Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tisue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706–3719
Krivit W, Lockman LA, Watkins PA et al (1995) The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. Journal of Inherited Metabolic Disease 18:398–412
Kurtzberg J, Laughlin M, Graham ML et al (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157–166
Lausen BF, Heilmann C, Vindelov L, Jacobsen N (1998) Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts. Bone Marrow Transplant 22:325–330
Lin MT, Storer B, Martin PJ et al (2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 349:2201–2210
Link H, Kolb HJ, Ebell W et al (1997) Die Transplantation hämatopoetischer Stammzellen. Teil II: Indikationen zur Transplantation von hämatopoetischen Stammzellen nach myelo-ablativer Therapie. Med Klin 92:534–545
Link H, Sens B, Dierich H et al (1990) Use of recombinant human erythropoietin after bone marrow transplantation. In: Freund M, Link H, Welte K (Hrsg) Cytokines in hemopoiesis, oncology and AIDS. Springer, Berlin-Heidelberg, S 483–487
Ljungman P et al (2003) Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantat 31:481–486
Locatelli F, Niemeyer C, Angelucci E et al (1997) Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 15:566–573
Lorenz E, Uphoff D, Reid TR, Shelton E (1951) Modification of irradiation injury in mice and guinea pigs by bone marrow injections. Journal of the National Cancer Institute 12:197–201
Main JM, Prehn RT (1955) Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. Journal of the National Cancer Institute 15:1023–1029
Majolino I, Cavallaro AM, Bacigalupo A et al (1997) Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO). Haematologica 82:47–52
Malachowski ME, Comenzo RL, Hillyer CD et al (1992) Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 32:732–735
Mannik JA, Lochte HL Jr, Ashley CA et al (1960) Autografts of bone marrow in dogs after lethal total-body radiation. Blood 15:255–266
Martin-Rendon E, Watt SM (2003) Exploitation of stem cell plasticity. Trans Med 13:325–349
Mathe G, Jammet H, Pendic B et al (1959) Transfusions et greffes de moelle osseuse homologue chez des humains irradiés a haute dose accidentellement. Rev Franc Etudes Clin Biol IV:226–238
Matthes-Martin S, Aberle SW, Peters C et al (1998) CMV-viraemia during allogenic bone marrow transplantation in pediatric patients: association with survival and graft-versus-host disease. Bone Marrow Transplant 21(suppl 2):53–56
McMillan ML, Auerbach AD, Davies SM et al (2000) Haematopoietic cell transplantation in patients with Fanconi anemia using alternate donors: results of a total body irradiation dose escalation study. Br J Haematol 109:121–129
Mickelson E, Petersdorf EW (1998) Histocompatibility. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, pp 28–37. Blackwell Science, Boston
Millot F, Esperou H, Bordigoni P et al (2003) Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Bone Marrow Transplant 32:993–999
Morishima Y, Sasazuki T, Inoki H et al (2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99:4200–4206
Nygaard R, Garwitz S, Haldorsen T et al (1991) Second malignant neoplasms in patients treated for childhood leukaemia. Acta Paediatr Scand 80:1220–1228
Okamoto Y, Takaue Y, Saito S et al (1993) Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 33:578–581
Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H (1996) Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775–2779
Ottinger HD, Ferencik S, Beelen DW et al (2003) Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 102:1131–1137
Ottinger HD, Grosse-Wilde M, Schmitz A, Grosse-Wilde H (1994) Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 14(suppl 4):34–38
Ottinger HD, Müller CR, Goldmann SF et al (2001) Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 80:706–714
Paul K, Kleinau I, Ebell W (2000) Pulmonale Komplikationen nach hämatopoetischer Stammzelltransplantation im Kindesalter. Pneumologie 54:191–200
Peggs KS, Verfuerth S, Pizzey A et al (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362:1375–1344
Peters C, Ladenstein R, Ochsenreiter W et al (1996) Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party. Bone Marrow Transplant Suppl 2:17–24
Petersdorf EW, Gooley TA, Anasetti C et al (998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92:3515–3520
Petersdorf EW, Gooley T, Malkki M et al (2001) The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 112:988–994
Petersdorf EW, Hansen JA, Martin PJ et al (2001) Major-histocompatibility-complex class I alleles and antigens in hematopoietic cell transplantation. N Engl J Med 345:1794–1800
Prasad VK, Kernan NA, Heller G et al (1999) HLA-C disparity between patients and unrelated donors matched for HLA-A,-B, and-DRB1 alleles: impact of serological vs. DNA typing for HLA-A and-B loci. Biol Blood Marrow Transplant 5:77–85
Reisner Y, Kapoor N, Kirkpatrick D et al (1983) Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatibility parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341–348
Reiter A, Schrappe M, Tiemann M et al (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy-a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 94:3294–3306
Reusser P, Einsele H, Lee J et al (2002) Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99:1159–1164
Rill DR, Santana VM, Roberts WM et al (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380–383
Ringdén O, Labopin M, Tura S et al (1996) A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukemia. Br J Haematol 93:637–645
Ringdén O, Remberger M, Runde V et al (1999) Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation. Blood 94:455–464
Rizzieri DA, Talbot JT, Long GD et al (2003) 4-hydroperoxycyclophosphamide-purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leucemia. Biol Blood Marrow Transplant 9:183–188
Rocha V, Cornish J, Sievers EL et al (2001) Comparison of outcome of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97:2962–2971
Rubinstein P, Carrier C, Scaradavou A et al (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Eng J Med 339:1565–1577
Sanders JE (1990) Late effects in children receiving total body irradiation for bone marrow transplantation. Radiother Oncol (suppl 1):82–87
Sanders J, Buckner CD, Bensinger WI et al (1987) Experience with marrow harvesting from donors less than two years of age. Bone Marrow Transplant 2:45–50
Sanders JE, Hawley J, Levy W et al (1996) Pregnancies following highdose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87:3045–3052
Sasazuki T, Juji T, Morishima Y et al (1998) Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 22:1177–1185
Schellong G, Pötter R, Brämswig JH et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. J Clin Oncol 17:3736–3744
Schrappe M, Reiter A, Zimmermann M et al (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia 14:2205–2222
Schmitz N, Linch DC, Dreger P et al (1996) Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353–357
Schreuder GMT, Hurley CK, Marsh SGE et al (2001) The HLA dictionary 2001: a summary of HLA-A,-B,-C,-DRB1/3/4/5,-DQB1 alleles and their association with serologically defined HLA-A,-B,-C,-DR and-DQ antigens. Tissue Antigens 58:109–140
Shank B (1993) Hyperfractionation (T.I.D.) vs. single dose irradiation in human acute lymphocytic leukemia cells: application to TBI for marrow transplantation. Radiother Oncol 27:30–35
Shank B, Brochstein JA, Castro-Malaspina H et al (1988) Immunosuppression prior to marrow transplantation for sensitized aplastic anemia patients: comparison of TLI with TBI. Int Radiat Oncol Biol Phys 14:1133–1141
Shapiro E, Krivit W, Lockman L et al (2000) Long-term effect of bonemarrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356:713–718
Slattery JT (2003) Intravenous versus oral busulfan — perhaps not as different as suggested. Biol Blood Marrow Transplant 9:282–284
Slavin S, Ackerstein A, Naparstek E, Or R, Weiss L (1990) The graftversus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplant 6:155–161
Slavin S, Nagler A, Naparstek E et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow tranplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 91:756–763
Socié G, Salooja N, Cohen A et al (2003) Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101:3373–3385
Sokos DR, Berger M, Lazarus HM (2002) Intravenous immunoglo bulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8:117–130
Storb R, Rudolph RH, Thomas ED (1971) Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture. J Clin Invest 50:1272–1275
Strasser SI, McDonald GB (1998) Gastrointestinal and hepatic complications. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, pp 627–610. Blackwell Science, Boston
Stroncek DF, Clay ME, Petzoldt ML et al (1996) Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36:601–610
Stroncek DF, Holland PV, Bartch G et al (1997) Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 81:1940–1946
Sykes M, Strober S (1998) Mechanisms of tolerance. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, pp 264–286. Blackwell Science, Boston
Thomas ED (1999) A history of haematopoietic cell transplantation. Br J Haematol 105:330–339
Thomas ED, Bryant JI, Buckner CD et al (1971) Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs. Trans Assoc Am Physicians 84:248–261
Thomas ED, Lochte HL, Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491–496
Toennies H, Huber S, Kuehl JS et al (2003) Clonal chromosome aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood 101:3872–3874
Uderzo C, Balduzzi A, De Lorenzo P et al (2001) Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 28(suppl 1):22–24
Van Rood JJ, van Leeuwen A (1963) Leucocyte grouping. A method and its application. J Clin Invest 42:1382–1390
Vitale V, Barra S, Corvo R, Bacigalupo A, van Lint MT, Locatelli F (1991) The role of thoraco-abdominal irradiation before marrow transplantation. Bone Marrow Transplant 7(suppl 3):35–36
Vossen JM, Breedeveld L, Bakker JDJ et al (2002) Chronic graft-versushost disease and its management in children. Rep Pract Oncol Radiother 7:133–138
Wade JA, Hurley CK, Takemoto SK et al (2003) HLA mismatching within or outside of cross reactive groups (CREG) is associated with similar outcomes after unrelated donor bone marrow transplant. Blood. In press
Wagner J, Barker J, Defor T et al (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611–1618
Wagner JE, Thompson JS, Carter S et al (2002) Impact of graft-versushost disease (GVHD) prophylaxis on 3-year disease-free survival (DFS): results of a multi-center, randomized phase II-III trial comparing T cell depletion/cyclosporine (TCD) and methotrexate/cyclosporine (M/C) in 410 recipients of unrelated donor bone marrow (BM). Blood 100:75a
Weisdorf DJ, Billett AL, Hannan P et al (1997) Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 90:2962–2968
Welte K, Gabrilove J, Bronchud MH et al (1996) Filgrastim (r-metHuGCSF): the first 10 years. Blood 88:1907–1929
Williams DA, Baum C (2003) Medicine. Genetherapy-new challenges ahead. Science 302:415–419
Woods WG, Neudorf S, Gold S et al (2001) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children’s Cancer Group. Blood 97:56–62
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Ebell, W. (2006). Hämatopoetische Stammzelltransplantation. In: Gadner, H., Gaedicke, G., Niemeyer, C., Ritter, J. (eds) Pädiatrische Hämatologie und Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29036-2_4
Download citation
DOI: https://doi.org/10.1007/3-540-29036-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-03702-6
Online ISBN: 978-3-540-29036-0
eBook Packages: Medicine (German Language)